Business Context and Reporting Period
This Form 8-K Current Report was filed by GridAI Technologies Corp. (formerly Entero Therapeutics, Inc.) on November 28, 2025. The filing reports significant corporate governance changes, including the resignation of two directors, the execution of a separation agreement, and a formal name and trading symbol change effective December 1, 2025.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only specific financial figure disclosed relates to a one-time separation payment.
- Separation Payment: $500,000 plus legal fees to be paid to former director Richard Paolone under a Separation Agreement and Mutual Release.
Material Changes
Board of Directors Resignations
- Eric Corbett: Resigned as a director on November 28, 2025. The resignation resulted from disagreements with management and the Board regarding governance policies, public disclosures, due diligence, and corporate governance practices.
- Richard Paolone: Resigned as a director on November 28, 2025. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
Corporate Identity Changes
- Name Change: The Company changed its name from "Entero Therapeutics, Inc." to "GridAI Technologies Corp." effective December 1, 2025.
- Trading Symbol: The Nasdaq Capital Market trading symbol changed from "ENTO" to "GRDX" effective December 1, 2025.
- CUSIP: The CUSIP number for the common stock remains unchanged.
Committee Composition
Following the resignations, the Board committees are now comprised of Ed Borkowski (Chair), Manpreet Uppal, and Geordan G. Pursglove for both the Audit and Compensation Committees.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, financial outlook, or management commentary regarding future business performance. The primary risk disclosed is the internal governance conflict that led to the resignation of Director Eric Corbett.
Investor Verification Checklist
- Verify the full text of the Separation Agreement (Exhibit 10.1) to understand the specific terms of the $500,000 payment and legal fee reimbursement to Richard Paolone.
- Review the resignation letter from Eric Corbett (Exhibit 99.1) to assess the specific nature of the governance disagreements.
- Confirm the trading symbol change to "GRDX" on the Nasdaq Capital Market effective December 1, 2025.
- Monitor future filings for the appointment of new directors to replace the resigned members and restore full committee functionality.